Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Proteomics and recurrence of atrial fibrillation: a pilot study nested in the PREDIMAR trial

  • Razquin, Cristina
  • Fernández Irigoyen, Joaquín
  • Barrio-López, María Teresa
  • López, Begoña
  • Ravassa, Susana
  • Ramos, Pablo
  • Macías-Ruiz, Rosa
  • Ibáñez Criado, Alicia
  • Santamaría Martínez, Enrique
  • Goñi, Leticia
  • Castellanos, Eduardo
  • Ibáñez Criado, José Luis
  • Tercedor, Luis
  • García-Bolao, Ignacio
  • Martínez González, Miguel Ángel
  • Almendral, Jesús
  • Ruiz Canela, Miguel
Introduction: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide. Although catheter ablation is the most efficacious therapy, relapses occur frequently (30%) in the first year after ablation. Novel biomarkers of recurrence are needed for a better prediction of recurrence and management of AF. In this pilot study, we aimed to analyze the baseline proteome of subjects included in a case-control study to find differential proteins associated with AF recurrence. Methods: Baseline serum proteomics (354 proteins) data from 16 cases (recurrent AF) and 17 controls (non-recurrent) were obtained using MS/MS analysis. A false discovery rate was performed using a nonlinear fitting method for the selection of proteins. Logistic regression models were used to further analyze the association between differentially expressed proteins and AF recurrence. Results: Ten proteins were differentially represented in cases vs. controls. Two were upregulated in the cases compared to the controls: keratin type I cytoskeletal 17 (Fold-change [FC] = 2.14; p = 0.017) and endoplasmic bifunctional protein (FC = 1.65; p = 0.032). Eight were downregulated in the cases compared to the controls: C4bpA (FC = 0.64; p = 0.006), coagulation factor XI (FC = 0.83; p = 0.011), CLIC1 (FC = 0.62; p = 0.017), haptoglobin (FC = 0.37; p = 0.021), Ig alpha-2 chain C region (FC = 0.49; p = 0.022), C4bpB (FC = 0.73; p = 0.028), N-acetylglucosamine-1- phosphotransferase subunit gamma (FC = 0.61; p = 0.033), and platelet glycoprotein Ib alpha chain (FC = 0.84; p = 0.038). Conclusion: This pilot study identifies ten differentially expressed serum proteins associated with AF recurrence, offering potential biomarkers for improved prediction and management., This study was supported by the Spanish Government Official Agency for funding biomedical research - Instituto de Salud Carlos III (ISCIII) - with competitive grants through the Fondo de Investigación Sanitaria y Fondo Europeo de Desarrollo Regional (PI17/00718, PI17/00748, PI17/01870) and ProteoRed; the Regional Government of Navarra (46/2016); and the Spanish Society of Cardiology (FEC/2016).